KOLs interviewed by GlobalData stressed the lack of biologic therapies specifically targeting T2-low asthma.

A NEW study has identified two key predictors of lung function decline in asthma: rising blood eosinophil counts over time ...

T2-Low Asthma: A Diagnostic and Therapeutic Challenge T2-low asthma presents unique challenges due to the absence of ...

The following is a summary of “Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the ...

The primary outcomes of this post hoc analysis were histologic and dysphagia symptom responses on the basis of esophageal ...

Innate immune cells are white blood cells that mediate innate immunity and include basophils, dendritic cells, eosinophils, Langerhans cells, mast cells, monocytes and macrophages, neutrophils and ...

Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study. Early improvement was linked to lower baseline FEV1 ...

PPI-responsive esophageal disease represents a subtype of eosinophilic esophagitis rather than GERD, according to comparative ...

Health care conferences this year showcased advancements in treatments for chronic obstructive pulmonary disease and sleep ...

Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharmacology & ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from ...

This subtype predominantly affects younger individuals. Eosinophils, a type of white blood cell, contribute significantly to airway inflammation, particularly during the late asthmatic response (LAR), ...